Irene Shui

Principal Scientist, Director of Epidemiology
Merck & Co., Inc

Poster(s):

• (B-224) Towards Optimizing Identification of First Line of Therapy (LOT) for Metastatic Lung, Breast and Colorectal Cancer in Real World Data: A Scoping Review
  Monday, August 25, 2025

  11:30 AM - 1:00 PM ET

• (B-013) Treatment Patterns on Early-Stage Melanoma: Results from a Multi-site Chart Review
  Monday, August 25, 2025

  11:30 AM - 1:00 PM ET